News Headlines Article

Approval For Drug That Treats Melanoma
New York Times

The first drug shown to prolong the lives of people with the skin cancer melanoma won approval from the Food and Drug Administration on Friday. The drug, Yervoy, was developed by Bristol-Myers Squibb and is a novel type of cancer drug that works by unleashing the body’s own immune system to fight tumors.

“This is really the first time in the melanoma field that there is a drug that extended survival in a meaningful way,” said Dr. Gerald P. Linette, an assistant professor of medicine at Washington University in St. Louis, who participated in a clinical trial of the drug.